<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0054">
 <label>54</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Baker</surname>
    <given-names>AF</given-names>
   </name>, 
   <name name-style="western">
    <surname>Dragovich</surname>
    <given-names>T</given-names>
   </name>, 
   <name name-style="western">
    <surname>Tate</surname>
    <given-names>WR</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma</article-title>. 
  <source>J Lab Clin Med</source>
  <year>2006</year>;
  <volume>147</volume>:
  <fpage>83</fpage>–
  <lpage>90</lpage>.
  <pub-id pub-id-type="pmid">16459166</pub-id>
 </mixed-citation>
</ref>
